The deregulated expression of MMP2 is thought to be involved in multiple pathways disorders causing cancers such as GC cancer, colorectal cancer (Bullock et al., 2013), melanoma (Godefroy et al., 2011), and prostate cancer (Biswas et al., 2010). Here, MMP2 is linked to prostate cancer.